{"accidental exposure to product": 20.7, "application site burn": 107.51, "application site discharge": 1639.39, "application site discolouration": 107.51, "application site discomfort": 157.2, "application site dryness": 208.53, "application site erosion": 854.95, "application site erythema": 218.22, "application site exfoliation": 602.37, "application site haemorrhage": 153.91, "application site infection": 449.02, "application site inflammation": 268.8, "application site irritation": 62.58, "application site oedema": 337.36, "application site pain": 67.56, "application site paraesthesia": 141.62, "application site pruritus": 41.79, "application site pustules": 1234.04, "application site reaction": 132.62, "application site scab": 2318.23, "application site scar": 131.8, "application site swelling": 131.13, "application site ulcer": 569.72, "application site vesicles": 852.32, "application site warmth": 68.06, "basal cell carcinoma": 12.58, "blister": 11.94, "burning sensation": 3.25, "burns second degree": 72.88, "conjunctivitis": 3.77, "dermatitis": 4.61, "dermatitis bullous": 5.1, "drug effective for unapproved indication": 49.06, "erythema": 3.91, "eye irritation": 7.45, "eye pain": 7.13, "eye swelling": 17.07, "eyelid oedema": 15.95, "inappropriate schedule of product administration": 7.16, "incorrect dose administered": 6.32, "incorrect product administration duration": 115.97, "lacrimation increased": 3.04, "medication error": 2.43, "ocular hyperaemia": 2.17, "periorbital oedema": 37.44, "periorbital swelling": 20.53, "post inflammatory pigmentation change": 174.0, "product administered at inappropriate site": 201.25, "product administration error": 22.02, "product dispensing error": 10.29, "product storage error": 4.59, "product use in unapproved indication": 6.13, "scab": 25.3, "skin burning sensation": 9.68, "skin exfoliation": 8.65, "skin reaction": 5.59, "squamous cell carcinoma": 42.73, "squamous cell carcinoma of skin": 98.62, "swelling": 2.42, "swelling face": 4.82, "swelling of eyelid": 19.96}